FDA Gives Firms With RiskMAP Drugs 6 Months To Submit Strategy Proposals
This article was originally published in The Pink Sheet Daily
Executive Summary
Makers of 16 approved drugs have until Sept. 21 to submit Risk Evaluation and Mitigation Strategy proposals to FDA.